Abstract:SESSION TITLE: Systemic Disease SESSION TYPE: Case Report Poster PRESENTED ON: Sunday, April 17, 2016 at 11:45 AM - 12:45 PM INTRODUCTION: There was limited understanding of the impact on obstructive sleep apnea (OSA) in highlanders and the accompanying changes when descending to lower altitude. A small-scale study showed that highlanders with OSA had an increased duration of OSA when descending to sea level. CASE PRESENTATION: A 34-year-old male highlander living at 2200 meters altitude was hospitalized at West China Hospital, Chengdu. No specific findings were obtained except for polycythemia (hemoglobin 226 g/L). As heavy snoring and witnessed apneas, a standard in-lab polysomnography were performed. PSG showed apnea-hypopnea index (AHI) was 28.6/ h with a mean duration of 1.22 min. The longest OSA event was 6.3 min (Figure 1 A, B). An overnight continuous positive airway pressure (CPAP) titration was performed. His AHI reduced to 3.7/ h, with optimal pressure of 13 cm H2O. Ten days later after he returned to high altitude, an overnight at home PSG recording (Figure 1 C) showed that shorter duration of the longest (6.3 min to 3.5 min) and averaged (1.22 min to 0.8 min) OSA events, as well as higher AHI (28.6/ h to 60/ h) as compared to at sea level. The rest of follow-up examinations were carried out in West China Hospital. After one month CPAP therapy at high altitude, his headache and dizziness were completely remitted. At 2nd and 3rd month (Figure 1 D) follow-ups, overnight PSG recordings showed that the longest duration of OSA events were shortened to 3.8 and 3.5 min, and mean duration reduced to 0.9 and 0.82 min at sea level, respectively. This patient’s hemoglobin level was parallel decreased with shortened duration of the longest OSA events (Figure 1 E). DISCUSSION: The finding is consistent with some previous studies, which suggested OSA highlanders had an increased duration of OSA events at sea level. Thus, the combination effects of decreased CO2 sensitivity and high level of hemoglobin may synergistically contribute to the extremely long OSA duration. In the current case, the remission of headache and dizziness symptoms was closely associated with a parallel reduction in hemoglobin after continuous CPAP therapy suggested OSA contributed to the development of polycythemia related headache and dizziness. As the improvement of recurrent intermittent hypoxia during sleep under continuous CPAP therapy, his hemoglobin level and the longest duration of OSA event at sea level progressively reduced. Clinically, the readily reversibility of the clinical symptoms, polycythemia and long OSA events upon CPAP therapy will suggest the heightened need to watch out for the occurrence of OSA among highlanders. CONCLUSIONS: We hypothesized that the occurrence of OSA may compromise the adaptive hypoxic response mechanism in highlanders. The readily reversibility by CPAP will suggest the heightened clinical need to recognize the occurrence of OSA in highlanders. Reference #1: Patz D, Spoon M, Corbin R et al. The effect of altitude descent on obstructive sleep apnea. Chest 2006;130 (6):1744-50. DISCLOSURE: The following authors have nothing to disclose: Lu Tan, Yun Li, Junying Zhou, Jihui Zhang, Rong Ren, Yun-Kwok Wing, Xiangdong Tang No Product/Research Disclosure Information

Altitude-dependent Variation in Lipoprotein Profile as a Predictor of Hypoxic Pulmonary Arterial Hypertension in COPD Patients: An Analysis Across Gradient Altitudes

Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes

Prevalence of Chronic Obstructive Pulmonary Disease at High Altitude: a Systematic Review and Meta-Analysis

THE PREVALENCE AND RISK FACTORS OF HIGH-ALTITUDE PULMONARY HYPERTENSION AMONG THE HIGHLANDERS IN TIBETAN AREA

High altitudes and partial pressure of arterial oxygen in patients with chronic obstructive pulmonary disease - A systematic review and meta-analysis

Prevalence and Risk Factors for COPD at High Altitude: A Large Cross-Sectional Survey of Subjects Living Between 2,100–4,700 m Above Sea Level

Hemoglobin is associated with hypertension-mediated cardiovascular damages in hypertensive patients with high-altitude polycythemia

[Clinical characteristics of acute pulmonary embolism at different altitudes in plateau areas]

Diagnostic value of CT in patients with stable chronic obstructive pulmonary disease at high altitude: Observational study

Systemic Blood Predictors of Elevated Pulmonary Artery Pressure Assessed by Non-invasive Echocardiography After Acute Exposure to High Altitude: A Prospective Cohort Study

The Effect of Chronic Altitude Exposure on COPD Outcomes in the SPIROMICS Cohort

The Prevalence and Risk Factors of High-Altitude Pulmonary Hypertension among Native Tibetans in Sichuan Province, China.

Serum High-Density Lipoprotein Cholesterol is Significantly Associated with the Presence and Severity of Pulmonary Arterial Hypertension: A Retrospective Cross-Sectional Study.

Longer Apnea Duration at Low Altitude in Tibetan and Han Highlanders Compared with Han Lowlanders: A Retrospective Study

The Nonlinear Relationship Between High-Density Lipoprotein and Changes in Pulmonary Structure Function and Pulmonary Function in COPD Patients in China

[Factors Affecting Pulmonary Arterial Pressure in Response to High-Altitude Hypoxic Stress].

ARGININE METABOLISM AND ARTERIAL STIFFNESS IN HIGHLANDERS WITH HIGH ALTITUDE POLYCYTHEMIA

Prolonged Duration of Sleep Apnea Events and Polycythemia for Highlanders at Sea Level

Clinical and Radiological Features of COPD Patients Living at ≥3000 M above Sea Level in the Tibet Plateau

[Retrospective analysis of clinical characteristics of patients with metabolic-associated fatty liver disease at high and low altitude areas]

Research Progress of Inflammatory Factors in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension at High Altitude.